Phenobarbital for epilepsy: Much is still to be learnt [3]

British Medical Journal

Volumn 330, Issue 7495, 2005, Pages 846-

  Reynolds, Edward H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ANTICONVULSIVE AGENT;

DEVELOPING COUNTRY; EPILEPSY; HUMAN; LEARNING; LETTER; PATIENT CARE; PRIORITY JOURNAL; NOTE;

ANTICONVULSANTS; EPILEPSY; HUMANS; PHENOBARBITAL;

EID: 17244362258     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Kale R, Perucca E. Revisiting phenobarbital for epilepsy. BMJ 2004;329:1199-200. (20 November.)
2. Reynolds EH, ed. Epilepsy in the world: launch of the second phase of the ILAE/IBE/WHO global campaign against epilepsy. Epilepsia 2002;43(suppl 6):1-3.
3. Heller AJ, Chesterman P, Elwes RD, Crawford P, Chadwick D, Johnson AL, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy; a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58:44-50.
4. De Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BG, et al. Randomised comparative monotherapy trial of Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-13.
5. Beghi E, Gatti G, Tonini C, Ben-Menachem E, Chadwick DW, Nikanorova M, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res 2003;57:1-13.